ERYTECH provides financial update for Q1 2014 admERY May 15, 2014 Newsroom ERYTECH provides a financial update for the first quarter of 2014. You Might Also Like Erytech to Hold Q1 2016 Business Update Conference Call on May 11th, 2016 May 2, 2016 ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014 ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018 July 17, 2018
ERYTECH receives Orphan Drug Designation by the FDA for eryaspase in Acute Myeloid Leukemia April 2, 2014
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018 July 17, 2018
